TAH Experience & Use

During 35+ years of clinical use and more than 1,700 implants worldwide, the SynCardia temporary Total Artificial Heart (TAH) has been used in patients with a variety of pre-implant etiologies that have contributed to irreversible biventricular failure. For more information about which patients should be considered for the SynCardia TAH, visit our Patient Selection page or download our Patient Selection Guide.

Most Common Pre-Implant Etiologies*

Idiopathic Dilated Cardiomyopathy

560+

Cases

Ischemic
Cardiomyopathy

470+

Cases

Congenital and Genetic Conditions

125+

Cases

Post-Heart Transplant Graft Failure

110

Cases

Valvular
Cardiomyopathy

85+

Cases

Restrictive
Cardiomyopathy

85+

Cases

LVAD Failures (Device Malfunction or RV Failure)

75+

Cases

Source: As reported on SynCardia Implant Forms and in published scientific papers as of 15 Dec 2017. Not all Implant Forms have complete information.

*Note: Some patients have multiple pre-implant etiologies and are counted as a case under more than one category.

Reliable, Long-Term Support

Several patients have been supported by the TAH for more than 4.5 years.

Source: As reported on SynCardia Implant Forms and Explant Forms as of 9 Oct 2017. Not all Implant Forms have complete information.

Providing Hope to the Sickest Patients

Patient INTERMACS Profile at Time of TAH Implant

  • Profile 1: Critical cardiogenic shock

  • Profile 2: Progressive decline

  • Profile 3: Stable but inotrope dependent

  • Profile 4: Resting symptoms

  • Profile 5: Exertion intolerant

  • Profile 6: Exertion limited

  • Profile 7: Advanced NYHA Class 3

TAH Outcomes at 12 Months

  • Overall Success Rate: 67.6%
  • Transplanted: 53.5%
  • Alive on Device: 14.1%

Source: INTERMACS Quarterly Statistical Report for SynCardia Systems, Inc. 2017 Q3

Visit our Professional Papers page to learn more about the use and experience with the Total Artificial Heart at different hospitals around the world.